Myriad Genetics
MYGN
#6860
Rank
NZ$1.06 B
Marketcap
NZ$11.48
Share price
0.30%
Change (1 day)
-56.93%
Change (1 year)

Market capitalization of Myriad Genetics (MYGN)

Market cap: NZ$1.06 Billion

As of January 2026 Myriad Genetics has a market cap of NZ$1.06 Billion. This makes Myriad Genetics the world's 6860th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Myriad Genetics from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$1.06 B2.57%
2025NZ$1.04 B-51.85%
2024NZ$2.16 B-20.15%
2023NZ$2.71 B46.49%
2022NZ$1.85 B-42.61%
2021NZ$3.22 B56.15%
2020NZ$2.06 B-31.4%
2019NZ$3.01 B-5.05%
2018NZ$3.17 B-5.26%
2017NZ$3.34 B103.37%
2016NZ$1.64 B-63.53%
2015NZ$4.51 B45.23%
2014NZ$3.10 B64.62%
2013NZ$1.88 B-29.88%
2012NZ$2.69 B18.47%
2011NZ$2.27 B-14.81%
2010NZ$2.66 B-22.91%
2009NZ$3.46 B-34.8%
2008NZ$5.30 B97.49%
2007NZ$2.68 B51.66%
2006NZ$1.77 B48.86%
2005NZ$1.19 B22.86%
2004NZ$0.96 B80.5%
2003NZ$0.53 B-28.74%
2002NZ$0.75 B-74.97%
2001NZ$3.01 B-30.07%
2000NZ$4.30 B375.56%
1999NZ$0.90 B406.85%
1998NZ$0.17 B-54.04%
1997NZ$0.38 B23.92%
1996NZ$0.31 B

End of Day market cap according to different sources

On Jan 10th, 2026 the market cap of Myriad Genetics was reported to be:

NZ$1.06 Billion
by Nasdaq info icon info icon
NZ$1.06 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Bio-Rad Laboratories
BIO
NZ$15.23 B 1,324.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
NZ$33.79 B 3,059.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
NZ$1.99 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$19.75 B 1,746.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$382.25 B 35,631.63%๐Ÿ‡บ๐Ÿ‡ธ USA